Physicians' Academy for Cardiovascular Education
Click here to watch this as part of CME accredited course

Cardiovascular outcomes & atherosclerosis: How do GLP-1RA provide benefit?

Click on video for subtitling in English, German, Italian, Spanish, French, Chinese

10' education - Sep. 24, 2020 - Jorge Plutzky, MD - Boston, MA, USA - Online CME

Click here to watch this as part of CME accredited course

Video navigation menu

  • What is the basis for benefit of GLP-1RA? 00:34
  • Factors that could lead to different results in CVOTs 02:24
  • Is atherosclerosis distinct in the context of diabetes? 06:30
  • Multiple sites of action of GLP-1 07:57
  • Cardiac and vascular effects of GLP-1 10:50


Show transcript

Educational information

This lecture by Jorge Plutzky was part of an accredited symposium "Expanding focus for cardiologists - The diabetic patient and cardiovascular outcomes" held during the virtual ESC Congress 2020.


Jorge Plutzky, cardiologist in the Brigham and Women's Hospital and Associate Prof at the Harvard Medical School in Boston, MA, USA.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

Click here for the meeting report View slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: